Cargando…
Virus‐Mimic mRNA Vaccine for Cancer Treatment
An effective therapeutic cancer vaccine should be empowered with the capacity to overcome the immunosuppressive tumor microenvironment. Here, the authors describe a mRNA virus‐mimicking vaccine platform that is comprised of a phospholipid bilayer encapsulated with a protein‐nucleotide core consistin...
Autores principales: | Meng, Chaoyang, Chen, Zhe, Mai, Junhua, Shi, Qing, Tian, Shaohui, Hinkle, Louis, Li, Jun, Zhang, Zhe, Ramirez, Maricela, Zhang, Licheng, Xu, Yitian, Zhang, Jilu, Pan, Ping‐Ying, Chen, Shu‐Hsia, Li, Hangwen, Shen, Haifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646380/ https://www.ncbi.nlm.nih.gov/pubmed/34901386 http://dx.doi.org/10.1002/adtp.202100144 |
Ejemplares similares
-
An mRNA vaccine elicits STING-dependent antitumor immune responses
por: Chen, Zhe, et al.
Publicado: (2023) -
A heparan-sulfate-bearing syndecan-1 glycoform is a distinct surface marker for intra-tumoral myeloid-derived suppressor cells
por: Welte, Thomas, et al.
Publicado: (2021) -
Identification of an Aptamer With Binding Specificity to Tumor-Homing Myeloid-Derived Suppressor Cells
por: Tian, Shaohui, et al.
Publicado: (2022) -
Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles
por: Xu, Yitian, et al.
Publicado: (2022) -
Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis
por: Shen, Qi, et al.
Publicado: (2018)